Researchers have developed an artificial intelligence (AI) approach that accelerates the identification of genes that contribute to neurodevelopmental conditions such as autism spectrum disorder, epilepsy and developmental delay. This new powerful computational tool can help fully characterize the genetic landscape of neurodevelopmental disorders, which is key to making accurate molecular diagnosis, elucidating disease mechanism and developing targeted therapies. The study appeared in the American Journal of Human Genetics.
“Although researchers have made major strides identifying different genes associated with neurodevelopmental disorders, many patients with these conditions still do not receive a genetic diagnosis, indicating that there are many more genes waiting to be discovered,” said first and co-corresponding author Dr. Ryan S. Dhindsa, assistant professor of pathology and immunology at Baylor College of Medicine and principal investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital.
Typically, to discover new genes associated with a disease, researchers sequence the genomes of many individuals with the disorders and compare them to the genomes of people without the disorders.
We took a complementary approach. We used AI to find patterns among genes already linked to neurodevelopmental diseases and predict additional genes that might also be involved in these disorders.”
Dr. Ryan S. Dhindsa, assistant professor of pathology and immunology, Baylor College of Medicine
The researchers looked for patterns in gene expression measured at the single-cell level from the developing human brain. “We found that AI models trained solely on these expression data can robustly predict genes implicated in